Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$887M |
| 2 |
Amazon
AMZN
|
+$857M |
| 3 |
Apple
AAPL
|
+$844M |
| 4 |
Microsoft
MSFT
|
+$802M |
| 5 |
Tesla
TSLA
|
+$606M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$258M |
| 4 |
Oracle
ORCL
|
+$126M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.53% |
| 2 | Financials | 13.97% |
| 3 | Healthcare | 13.42% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EAR
3576
DELISTED
Eargo, Inc. Common Stock
EAR
| $1.23M | ﹤0.01% |
9,154
-4,558
| -33% | -$2.43M |
|
3577
Asure Software
ASUR
$251M
| $1.23M | ﹤0.01% |
136,667
| – | – |
|
3578
Rallybio
RLYB
$90.1M
| $1.23M | ﹤0.01% |
+8,745
| New | +$1.03M |
|
|
ENZ
3579
DELISTED
Enzo Biochem, Inc.
ENZ
| $1.23M | ﹤0.01% |
346,485
-2,736
| -0.8% | -$9.13K |
|
3580
SELLAS Life Sciences
SLS
$2.5B
| $1.23M | ﹤0.01% |
133,801
+32,464
| +32% | +$301K |
|
|
SRT
3581
DELISTED
Startek Inc.
SRT
| $1.22M | ﹤0.01% |
221,543
-110
| -0% | -$677 |
|
3582
STRATTEC Security
STRT
$338M
| $1.22M | ﹤0.01% |
31,313
-147
| -0.5% | -$5.9K |
|
|
SAL
3583
DELISTED
Salisbury Bancorp, Inc.
SAL
| $1.22M | ﹤0.01% |
46,298
+2,982
| +7% | +$74K |
|
|
SCR
3584
DELISTED
Score Media and Gaming Inc. Class A Subordinate Voting Shares
SCR
| $1.21M | ﹤0.01% |
35,465
+10,765
| +44% | +$297K |
|
|
XEC
3585
DELISTED
CIMAREX ENERGY CO
XEC
| $1.21M | ﹤0.01% |
13,927
-1,241,592
| -99% | -$86.2M |
|
|
REV
3586
DELISTED
Revlon, Inc.
REV
| $1.21M | ﹤0.01% |
119,293
+2,911
| +3% | +$32.8K |
|
|
SACH
3587
Sachem Capital Corp
SACH
$37.6M
| $1.2M | ﹤0.01% |
219,711
+46,325
| +27% | +$235K |
|
|
WMPN
3588
DELISTED
William Penn Bancorporation Common Stock
WMPN
| $1.19M | ﹤0.01% |
97,811
+9,149
| +10% | +$111K |
|
|
EMAN
3589
DELISTED
eMagin Corporation
EMAN
| $1.19M | ﹤0.01% |
527,451
+14,299
| +3% | +$37.9K |
|
3590
Aqua Metals
AQMS
$10.1M
| $1.19M | ﹤0.01% |
2,877
+30
| +1% | +$13.6K |
|
3591
Chunghwa Telecom
CHT
$32.8B
| $1.19M | ﹤0.01% |
30,220
+6,735
| +29% | +$275K |
|
|
FSFG
3592
DELISTED
First Savings Financial Group
FSFG
| $1.19M | ﹤0.01% |
42,237
+15,546
| +58% | +$414K |
|
3593
Shinhan Financial Group
SHG
$35.1B
| $1.19M | ﹤0.01% |
35,227
-2,205
| -6% | -$73.7K |
|
3594
MainStreet Bancshares
MNSB
$179M
| $1.19M | ﹤0.01% |
49,400
+2,811
| +6% | +$66.3K |
|
|
CFRX
3595
DELISTED
ContraFect Corporation
CFRX
| $1.18M | ﹤0.01% |
3,657
+1,192
| +48% | +$371K |
|
|
TEAD
3596
Teads Holding Co
TEAD
$63.6M
| $1.18M | ﹤0.01% |
+79,945
| New | +$1.41M |
|
|
FARM
3597
DELISTED
Farmer Brothers
FARM
| $1.18M | ﹤0.01% |
140,593
+2,068
| +1% | +$19K |
|
|
ATYR
3598
aTyr Pharma
ATYR
$54.2M
| $1.18M | ﹤0.01% |
130,282
+20,521
| +19% | +$123K |
|
|
IVAC
3599
DELISTED
Intevac Inc
IVAC
| $1.18M | ﹤0.01% |
246,844
+23,893
| +11% | +$131K |
|
3600
Medallion Financial
MFIN
$262M
| $1.18M | ﹤0.01% |
150,108
| – | – |
|
Similar funds
Geode Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
- Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
- Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
- Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
- Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
- Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
- Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.